Literature DB >> 27597241

Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer.

Phillip J Gray1, Chun Chieh Lin2, Matthew R Cooperberg3, Ahmedin Jemal2, Jason A Efstathiou4.   

Abstract

BACKGROUND: Numerous management options exist for patients with prostate cancer; however, recent trends and their influencing factors are not well described.
OBJECTIVE: To describe modern patterns of care and factors associated with management choice using the National Cancer Database. DESIGN, SETTING, AND PARTICIPANTS: Patients with localized prostate cancer diagnosed between 2004 and 2012 were included and grouped according to National Comprehensive Cancer Network guidelines into low, intermediate, or high risk. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Trend analyses and multivariate logistic regression was used to identify factors associated with management. RESULTS AND LIMITATIONS: There were 598 640 patients who met the study criteria; 36.3% were classified as low risk, 43.8% intermediate risk, and 20.0% high risk. Over the study period, among low-risk patients, observation increased from 9.2% to 21.3%, while radical prostatectomy (RP) increased from 29.5% to 51.1% (p<0.001 for both). In contrast, external beam radiotherapy decreased from 24.3% to 14.5%, while brachytherapy decreased from 31.7% to 11.1%. A similar pattern was seen for patients with intermediate-risk or high-risk disease. Among high-risk patients, RP increased from 25.1% to 43.4% replacing external beam radiotherapy as the dominant therapy. On multivariate analysis, racial minorities, the uninsured, and low-income patients were less likely to receive RP. Low-risk patients in similar subgroups were significantly more likely to be observed. Limitations include potential miscoding or misclassification of variables.
CONCLUSIONS: Patterns of care in localized prostate cancer are changing rapidly. While use of observation is increasing in low-risk groups, the use of RP is increasing across all risk groups with a concomitant decline in use of radiotherapy. Socioeconomic factors appear to influence management choice. PATIENT
SUMMARY: In this report we identify a recent significant increase in the use of radical prostatectomy for prostate cancer patients. Socioeconomic factors such as race, insurance type, and income may affect treatments offered to and received by patients.
Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Androgen deprivation therapy; Localized; Practice patterns; Prostate cancer

Mesh:

Year:  2016        PMID: 27597241     DOI: 10.1016/j.eururo.2016.08.047

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  34 in total

Review 1.  Management of Urethral Stricture and Bladder Neck Contracture Following Primary and Salvage Treatment of Prostate Cancer.

Authors:  Brendan Michael Browne; Alex J Vanni
Journal:  Curr Urol Rep       Date:  2017-10       Impact factor: 3.092

2.  Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.

Authors:  Walter Rayford; Alp Tuna Beksac; Jordan Alger; Mohammed Alshalalfa; Mohsen Ahmed; Irtaza Khan; Ugo G Falagario; Yang Liu; Elai Davicioni; Daniel E Spratt; Edward M Schaeffer; Felix Y Feng; Brandon Mahal; Paul L Nguyen; Robert B Den; Mark D Greenberger; Randy Bradley; Justin M Watson; Matthew Beamer; Lambros Stamatakis; Darrell J Carmen; Shivanshu Awasthi; Jonathan Hwang; Rachel Weil; Harri Merisaari; Nihal Mohamed; Leslie A Deane; Dimple Chakravarty; Kamlesh K Yadav; Kosj Yamoah; Sujit S Nair; Ashutosh K Tewari
Journal:  Commun Biol       Date:  2021-06-03

3.  A CD24-p53 axis contributes to African American prostate cancer disparities.

Authors:  Wei Liu; Yue Zhang; Shi Wei; Sejong Bae; Wei-Hsiung Yang; Gary J Smith; James L Mohler; Elizabeth T H Fontham; Jeannette T Bensen; Guru P Sonpavde; Guo-Yun Chen; Runhua Liu; Lizhong Wang
Journal:  Prostate       Date:  2020-03-13       Impact factor: 4.104

4.  The relationship between hospital volume and outcomes of radical prostatectomy: a new perspective on an old story.

Authors:  Marco Paciotti; Vittorio Fasulo; Giovanni Lughezzani
Journal:  Gland Surg       Date:  2020-08

5.  Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer.

Authors:  Takashi Kobayashi; Kent Kanao; Motoo Araki; Naoki Terada; Yasuyuki Kobayashi; Atsuro Sawada; Takahiro Inoue; Shin Ebara; Toyohiko Watanabe; Tomomi Kamba; Makoto Sumitomo; Yasutomo Nasu; Osamu Ogawa
Journal:  Int J Clin Oncol       Date:  2017-11-11       Impact factor: 3.402

6.  Prostate Cancer: Community Education and Disparities in Diagnosis and Treatment.

Authors:  Bradley Carthon; Hannah C Sibold; Shannon Blee; Rebecca D Pentz
Journal:  Oncologist       Date:  2021-03-22

7.  Mechanistic modelling of prostate-specific antigen dynamics shows potential for personalized prediction of radiation therapy outcome.

Authors:  Guillermo Lorenzo; Víctor M Pérez-García; Alfonso Mariño; Luis A Pérez-Romasanta; Alessandro Reali; Hector Gomez
Journal:  J R Soc Interface       Date:  2019-08-14       Impact factor: 4.118

Review 8.  Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate Cancer.

Authors:  Robert T Dess; Todd M Morgan; Paul L Nguyen; Rohit Mehra; Howard M Sandler; Felix Y Feng; Daniel E Spratt
Journal:  Curr Urol Rep       Date:  2017-07       Impact factor: 3.092

9.  Utilization of Pelvic Lymph Node Dissection for Patients With Low-Risk Prostate Cancer Treated With Robot-Assisted Radical Prostatectomy.

Authors:  Parth K Modi; Megan Bock; Sinae Kim; Eric A Singer; Rahul R Parikh
Journal:  Clin Genitourin Cancer       Date:  2017-05-10       Impact factor: 2.872

10.  Trends in treatments for prostate cancer in the United States, 2010-2015.

Authors:  Jianwei Wang; Harry Hua-Xiang Xia; Yuanyuan Zhang; Lanjing Zhang
Journal:  Am J Cancer Res       Date:  2021-05-20       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.